These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 14553943)
1. Newly established Askin tumor cell line and overexpression of focal adhesion kinase in Ewing sarcoma family of tumors cell lines. Moritake H; Sugimoto T; Kuroda H; Hidaka F; Takahashi Y; Tsuneyoshi M; Yoshida MA; Cui Q; Akiyoshi K; Izumi T; Nunoi H Cancer Genet Cytogenet; 2003 Oct; 146(2):102-9. PubMed ID: 14553943 [TBL] [Abstract][Full Text] [Related]
2. Does malignant small round cell tumor of the thoracopulmonary region (Askin tumor) constitute a clinicopathologic entity? An analysis of 30 cases with immunohistochemical and electron-microscopic support treated at the Institute Gustave Roussy. Contesso G; Llombart-Bosch A; Terrier P; Peydro-Olaya A; Henry-Amar M; Oberlin O; Habrand JL; Dubousset J; Tursz T; Spielmann M Cancer; 1992 Feb; 69(4):1012-20. PubMed ID: 1310431 [TBL] [Abstract][Full Text] [Related]
3. High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing Sarcoma. Wang S; Hwang EE; Guha R; O'Neill AF; Melong N; Veinotte CJ; Conway Saur A; Wuerthele K; Shen M; McKnight C; Alexe G; Lemieux ME; Wang A; Hughes E; Xu X; Boxer MB; Hall MD; Kung A; Berman JN; Davis MI; Stegmaier K; Crompton BD Clin Cancer Res; 2019 Jul; 25(14):4552-4566. PubMed ID: 30979745 [TBL] [Abstract][Full Text] [Related]
4. Primary Ewing sarcoma of the stomach--a newly described entity. Rafailidis S; Ballas K; Psarras K; Pavlidis T; Symeonidis N; Marakis G; Sakadamis A Eur Surg Res; 2009; 42(1):17-20. PubMed ID: 18971581 [TBL] [Abstract][Full Text] [Related]
5. Molecular cytogenetic characterization of two established ESFT cell lines. Ishiguro M; Yuki M; Fukushige T; Mizoguchi M; Kaneko Y; Morishige T; Iwasaki H Hum Cell; 2017 Jan; 30(1):41-48. PubMed ID: 27613543 [TBL] [Abstract][Full Text] [Related]
6. High-throughput tyrosine kinase activity profiling identifies FAK as a candidate therapeutic target in Ewing sarcoma. Crompton BD; Carlton AL; Thorner AR; Christie AL; Du J; Calicchio ML; Rivera MN; Fleming MD; Kohl NE; Kung AL; Stegmaier K Cancer Res; 2013 May; 73(9):2873-83. PubMed ID: 23536552 [TBL] [Abstract][Full Text] [Related]
7. Synchronous presentation of an Askin tumor and a plasmacytoma in an adult patient. Fresco R; Saldombide L; Suárez L Tumori; 2003; 89(3):324-7. PubMed ID: 12908792 [TBL] [Abstract][Full Text] [Related]
8. CXCL16 and CXCR6 in Ewing sarcoma family tumor. Na KY; Kim HS; Jung WW; Sung JY; Kalil RK; Kim YW; Park YK Hum Pathol; 2014 Apr; 45(4):753-60. PubMed ID: 24507753 [TBL] [Abstract][Full Text] [Related]
9. TAE226, a dual inhibitor of focal adhesion kinase and insulin-like growth factor-I receptor, is effective for Ewing sarcoma. Moritake H; Saito Y; Sawa D; Sameshima N; Yamada A; Kinoshita M; Kamimura S; Konomoto T; Nunoi H Cancer Med; 2019 Dec; 8(18):7809-7821. PubMed ID: 31692287 [TBL] [Abstract][Full Text] [Related]
10. EWS-FLI-1 and EWS-ERG chimeric mRNAs in Ewing's sarcoma and primitive neuroectodermal tumor. Ida K; Kobayashi S; Taki T; Hanada R; Bessho F; Yamamori S; Sugimoto T; Ohki M; Hayashi Y Int J Cancer; 1995 Nov; 63(4):500-4. PubMed ID: 7591257 [TBL] [Abstract][Full Text] [Related]
11. Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells. Agochiya M; Brunton VG; Owens DW; Parkinson EK; Paraskeva C; Keith WN; Frame MC Oncogene; 1999 Oct; 18(41):5646-53. PubMed ID: 10523844 [TBL] [Abstract][Full Text] [Related]
12. The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors. Mendiola M; Carrillo J; García E; Lalli E; Hernández T; de Alava E; Tirode F; Delattre O; García-Miguel P; López-Barea F; Pestaña A; Alonso J Int J Cancer; 2006 Mar; 118(6):1381-9. PubMed ID: 16206264 [TBL] [Abstract][Full Text] [Related]
13. Radiological and pathological diagnosis of an incidental Askin tumor. Covello B; Hartman S; Kaufman S; Enrizo O Radiol Case Rep; 2021 Jun; 16(6):1245-1248. PubMed ID: 33868529 [TBL] [Abstract][Full Text] [Related]
14. Ewing's sarcoma oncoprotein EWS-FLI1: the perfect target without a therapeutic agent. Uren A; Toretsky JA Future Oncol; 2005 Aug; 1(4):521-8. PubMed ID: 16556028 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic significance and clinical applications of chimeric genes in Ewing's sarcoma. Yoshino N; Kojima T; Asami S; Motohashi S; Yoshida Y; Chin M; Shichino H; Yoshida Y; Nemoto N; Kaneko M; Mugishima H; Suzuki T Biol Pharm Bull; 2003 May; 26(5):585-8. PubMed ID: 12736494 [TBL] [Abstract][Full Text] [Related]
16. Newly established clear cell sarcoma (malignant melanoma of soft parts) cell line expressing melanoma-associated Melan-A antigen and overexpressing C-MYC oncogene. Moritake H; Sugimoto T; Asada Y; Yoshida MA; Maehara Y; Epstein AL; Kuroda H Cancer Genet Cytogenet; 2002 May; 135(1):48-56. PubMed ID: 12072203 [TBL] [Abstract][Full Text] [Related]
17. Apoptotic responsiveness of the Ewing's sarcoma family of tumours to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL). Van Valen F; Fulda S; Truckenbrod B; Eckervogt V; Sonnemann J; Hillmann A; Rödl R; Hoffmann C; Winkelmann W; Schäfer L; Dockhorn-Dworniczak B; Wessel T; Boos J; Debatin KM; Jürgens H Int J Cancer; 2000 Oct; 88(2):252-9. PubMed ID: 11004677 [TBL] [Abstract][Full Text] [Related]